Collaborative Consult: Cases, Patient Reflection, and Discussions – What’s New in Pediatric Atopic Dermatitis (ID: I830a) Survey

1.How many years have you been in practice?(Required.)

>21

11-20

1-10

<1

2.How many patients with pediatric atopic dermatitis do you manage per week?(Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

3.Please select the option that best describes your practice setting.  (Required.)

4.After participating in this activity, how confident are you in the management of patients with atopic dermatitis in your practice? (Required.)

Very confident

Confident

Little confidence

No confidence

5.After participating in this activity, do you intend to incorporate newly FDA-approved therapies into your clinical practice for patients with moderate-to-severe atopic dermatitis aged ≥6 months?(Required.)

Yes, immediately

Will wait to hear from colleagues regarding experience with these agents in clinical practice

Will wait until additional clinical trial data becomes available

Will not incorporate into practice

6.How committed are you to making changes in your practice based on your participation in this activity?(Required.)

Very committed

Committed

Not committed

I do not plan to make changes

Not committed or do not plan to make changes (please indicate reason)

7.Which of the following best describes the impact of this activity on your performance?(Required.)

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

9.What barriers do you see to making changes in your practice?(Required.)

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

13.If you indicated that you perceived commercial bias or influence, please describe:

14.As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

15.Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for atopic dermatitis or related disease state: